Rodney Pommier, MD, FACS, professor of surgery, division of surgical oncology, school of medicine, Oregon Health & Science University, addresses the questions surrounding the efficacy of perioperative octreotide treatment for patients experiencing a carcinoid crisis.
Kaushal Nanavati, MD, assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center discusses how CBD and cannabinol can offer potential treatment options as more research is being brought to the forefront on these as integrative medicine.
Rodney Pommier, MD, FACS, professor of surgery, division of surgical oncology, school of medicine, Oregon Health & Science University, discusses what octreotide is and how it is used to reduce carcinoid crisis rates or treat a crisis.
NETs can occur almost anywhere in the body, although they are most common in the gastrointestinal tract and lungs.
Rodney Pommier, MD, FACS, professor of surgery, division of surgical oncology, school of medicine, Oregon Health & Science University, discusses his presentation at the 2021 NANETS Virtual Symposium on a prospective study of carcinoid crisis with no perioperative octreotide.
Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology at Fox Chase Cancer Center, discusses how communication plays a huge role in treatment of neuroendocrine tumors in large cancer centers.
Kaushal Nanavati, MD, assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center discusses why integrative treatment can help physicians personalize treatments for individuals with NETs and why it is beneficial to improve the quality of life for them.
Mei Ka Fong, PharmD, BCOP, said there are multiple treatment approaches for patients with NETs.
The CVS Health 2021 Health Care Insights Study found significant differences in how patients of various ages and genders approach care.
Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology at Fox Chase Cancer Center, discusses what kind of support services at large cancer centers can help individuals with neuroendocrine tumors with their treatment.
Kaushal Nanavati, MD, assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center, discusses how integrative medicine can help treatment of neuroendocrine tumors in combination with other treatments.
Pharmacists and technicians have an opportunity to prove their value as immunizers now that the Pfizer-BioNTech COVID-19 vaccine has been authorized for use in children ages 5 to 11.
Expert panelists delve into topics related to women's health and women's health care during the COVID-19 pandemic, including pregnancy and COVID-19 vaccine considerations and best practices for guiding decisions on birth control.
Board-certified oncology pharmacists Bhavesh Shah, RPh, BCOP; and Thomasina Morris, RPh, MHA, BCOP, talk about exciting ongoing PARP inhibitor research concerning ovarian cancer.
Lindsay Bealor Greenleaf, MBA, JD, Vice President of ADVI Health, discusses a new poll from the Kaiser Family Foundation that found that 83% of Americans believe the government should be allowed to negotiate lower drug prices, for both those on Medicare and in private insurance plans.
Mark Garofoli, director of Experiential Learning Program at WVU School of Pharmacy, discusses his CPhT 2021 conference presentation regarding the role and impact of pharmacy technicians on opioids in the pharmacy.
Linda Mendonça, DNP, RN, PHNA-BC, president of the National Association of School Nurses, discusses a new poll released by the COVID-19 Vaccine Education and Equity Project and the National Association of School Nurses about parents’ plans to vaccinate their school-aged children.
Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, on his recent presentations at Insight 2021 and the virtual Sana Symposium on psychedelic adverse effects and drug-drug interactions.
Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE, focuses on the safety and efficacy of systemic agents used to treat atopic dermatitis.
Emily Holcomb, PharmD, BCPS, ISMP Safe Medication Management Fellow, discusses her CPhT 2021 conference presentation regarding targeted medication safety best practices.
Nathan Bryson, PhD, chief scientific officer of Field Trip Health, said the company's new psychedelic compound, FT-104, could have potential uses in the treatment of postpartum depression.
In addition, some parents may still be unvaccinated, so counseling them on the safety and efficacy of the vaccines is important.
Gyang and Hansen discussed any new or existing treatment options for patients, the role of the pharmacist changing, and what they wish others knew about MS.
Paula Durlofsky, PhD, a writer for the American Psychological Association's Device Management and Digital Intelligence committee discusses how social media has impacted the mental health of health care professionals in recent years, including the COVID-19 Pandemic.
Bhavesh Shah, RPh, BCOP, and Thomasina Morris, RPh, MHA, BCOP, discuss toxicities to monitor for when using PARP inhibitors to battle ovarian cancer.
The Keep Up the Rates campaign is aiming to encourage patients to catch up on routine vaccinations that might have been missed or delayed due to the COVID-19 pandemic.
Amy Summers, PharmD, BCSCP, consultant at Restore Health Consulting, discusses her CPhT 2021 conference presentation regarding proposed changes to the USP <795> and <797>.
Gary Locke, former governor of Washington state, US Secretary of Commerce, and ambassador to China, discusses the World Trade Organization's TRIPS Council, which recently met to assess the elimination of IP protections for COVID-19 vaccines, diagnostics, and medical devices.
Walgreens Chief Medical Officer Kevin Ban, MD, said the Walgreens 2021-2022 Flu Index is showing high flu activity in several regions of the country.
Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.
